Form 4: Teva Pharmaceutical Industries: Executive Vice President Placid Jover Reports Acquisition of Restricted Share Units

Executive Vice President Placid Jover reports the acquisition of 51,311 restricted share units in Teva Pharmaceutical Industries on August 1, 2024.

Summary

• On August 1, 2024, Placid Jover, Executive Vice President and Chief Human Resources Officer of Teva Pharmaceutical Industries, acquired 51,311 restricted share units.
• These restricted share units vest in installments: 12,827 on each of August 1, 2025, August 1, 2026, and August 1, 2027, and 12,830 on August 1, 2028.
• Each restricted share unit represents a contingent right to receive one ordinary share or the cash value of one ordinary share, at the discretion of the Human Resources and Compensation Committee.
• The ordinary shares may be represented by American Depositary Shares (ADS), with each ADS currently representing one ordinary share.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard executive compensation transaction. It's neither particularly positive nor negative from an investment perspective.

Positives

• The grant of restricted share units aligns the executive's interests with the long-term performance of the company.
• The vesting schedule encourages continued service and commitment from the executive.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the restricted share units.

Industry Context

This filing is a routine disclosure of executive compensation in the pharmaceutical industry, where equity-based compensation is common to align management interests with shareholder value.

Comparison to Industry Standards

• Equity compensation is a standard practice among publicly traded pharmaceutical companies.
• Companies like Pfizer, Johnson & Johnson, and Novartis also utilize restricted stock units and stock options as part of their executive compensation packages.
• The vesting schedules and terms of these grants are generally comparable across the industry, with variations based on individual performance and company goals.

Stakeholder Impact

• The grant of restricted share units can potentially align management's interests with those of shareholders, encouraging long-term value creation.
• Employees may view executive compensation packages as a reflection of the company's commitment to its leadership.

Key Dates